Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status

Susan E. McCann*, Swati Kulkarni, Maurizio Trevisan, Dominica Vito, Jing Nie, Stephen B. Edge, Paola Muti, Jo L. Freudenheim

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

43 Scopus citations

Abstract

We examined the association of dietary lignan intake with estrogen receptor negative (ER-) and ER positive (ER+) breast cancer risk in a breast cancer case-control study. Among premenopausal women only, there was a reduced risk of ER- breast cancer for those in the highest compared to the lowest quartile of lignan intake suggesting that the observed negative association of lignans with breast cancer may be limited to ER- tumors.

Original languageEnglish (US)
Pages (from-to)309-311
Number of pages3
JournalBreast Cancer Research and Treatment
Volume99
Issue number3
DOIs
StatePublished - Oct 1 2006

Keywords

  • Breast cancer
  • Estrogen receptor
  • Lignans
  • Phytoestrogens

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status'. Together they form a unique fingerprint.

Cite this